CDW Corporation · CDW · FY2024 Q4 · Calendar Q1 2025
CDW: Cloud and healthcare strength offset a cautious outlook
The supplied analysis supports a balanced view: cloud, security, services and healthcare provide credible growth drivers, but public-sector timing, hardware pressure, competition and limited operating leverage keep the case conditional rather than established.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about CDW FY2024 Q4
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior quarter, the analysis points to stronger Q4 sales momentum, a roughly 30% healthcare growth contribution, continued double-digit cloud and services growth, and a maintained rather than lowered outlook. Management also highlighted the Mission Cloud Services acquisition and expanded AI and healthcare initiatives.
Guidance delta
Maintained. Management described a cautious 2025 outlook with low-single-digit IT-spend growth and a goal of outperforming the market by 200–300 basis points.
Key takeaways
- Q4 net sales grew 5% year over year, while full-year sales declined 1.8%.
- Healthcare grew about 30% and became a key profit driver.
- Cloud, SaaS, security and services grew double digits and supported gross-profit margins.
- Management maintained a cautious outlook and emphasized cloud, security, AI and selective M&A.
Management priorities
- Integrate Mission Cloud Services and expand AWS-focused offerings
- Accelerate cloud, security and data-analytics capabilities
- Develop healthcare transformation centers and AI solutions
- Pursue selective M&A in industry-specific and emerging technologies
- Maintain dividend growth and share repurchases
Follow CDW with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 11, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Barclays | Equal Weight | Equal Weight | Maintain | Sep 21, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Aug 6, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Jul 13, 2026 |
| JP Morgan | Overweight | Neutral | Upgrade | May 27, 2026 |
| UBS | Buy | Buy | Maintain | May 7, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | May 7, 2026 |
| Raymond James | Strong Buy | Outperform | Upgrade | Nov 25, 2025 |
| Stifel | Buy | Buy | Maintain | Jul 17, 2024 |
| Northcoast Research | Buy | Neutral | Upgrade | Jun 7, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | May 4, 2023 |
| B of A Securities | Neutral | Buy | Downgrade | Apr 19, 2023 |
| CFRA | Hold | Hold | Maintain | May 7, 2020 |
| Bank of America | Buy | Buy | Maintain | Jul 30, 2019 |
| Stifel Nicolaus | Hold | Buy | Downgrade | Apr 17, 2019 |
| Baird | Outperform | Neutral | Upgrade | May 9, 2017 |
| Deutsche Bank | Buy | Buy | Maintain | Aug 4, 2016 |
| Goldman Sachs | Buy | Buy | Maintain | Dec 1, 2015 |
| RBC Capital | Outperform | Outperform | Maintain | May 8, 2015 |
Named analyst price targets
Upside is calculated against the persisted current price $142.17. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Barclays | Analyst unavailable | $150 | $152.38 | +5.5% | Sep 8, 2026 |
| Morgan Stanley | Erik Woodring | $171 | $140.89 | +20.3% | Aug 6, 2026 |
| Morgan Stanley | Erik Woodring | $170 | $123.57 | +19.6% | Jun 23, 2026 |
| RBC Capital | Analyst unavailable | $130 | $108.59 | -8.6% | May 27, 2026 |
| UBS | Analyst unavailable | $147 | $113.08 | +3.4% | May 7, 2026 |
| Barclays | Analyst unavailable | $123 | $109 | -13.5% | May 7, 2026 |
| Raymond James | Analyst unavailable | $150 | $111.17 | +5.5% | May 6, 2026 |
| UBS | Analyst unavailable | $162 | $138.08 | +13.9% | Feb 5, 2026 |
| Barclays | Analyst unavailable | $144 | $138.08 | +1.3% | Feb 5, 2026 |
| Evercore ISI | Analyst unavailable | $180 | $127.51 | +26.6% | Jan 20, 2026 |
| Morgan Stanley | Analyst unavailable | $141 | $131.75 | -0.8% | Jan 20, 2026 |
| Morgan Stanley | Analyst unavailable | $177 | $145.02 | +24.5% | Dec 17, 2025 |
| Raymond James | Adam Tindle | $185 | $141.92 | +30.1% | Nov 25, 2025 |
| UBS | Analyst unavailable | $190 | $142.21 | +33.6% | Nov 5, 2025 |
| Barclays | Analyst unavailable | $148 | $141.66 | +4.1% | Nov 5, 2025 |
| Citigroup | Asiya Merchant | $245 | $226.3 | +72.3% | Oct 1, 2024 |
| Northcoast Research | Keith Housum | $270 | $224.24 | +89.9% | Jun 7, 2024 |
| J.P. Morgan | Analyst unavailable | $225 | $178.46 | +58.3% | Dec 20, 2022 |
| Stifel Nicolaus | Matthew Sheerin | $210 | $171.68 | +47.7% | Apr 18, 2022 |
| Morgan Stanley | Erik Woodring | $214 | $178.83 | +50.5% | Apr 4, 2022 |
Track every rating change on CDW the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationCDW Corporation specializes in delivering comprehensive information technology services and products across North America and the United Kingdom. It strategically targets three core client divisions: corporate enterprises, small to medium-sized businesses, and public sector organizations. Their portfolio encompasses both individual hardware and software offerings, alongside sophisticated integrated IT solution packages. These comprehensive solutions span on-premise, hybrid, and cloud environments, addressing critical areas such as data center infrastructure, network management, digital workspace enablement, and robust security.…
Historical context
All CDW earningsTechnology peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| ACN Accenture plc | FY2026 Q4 · Calendar Q4 2026 | +3.5% | +15.8% | Accenture: AI demand supports strong Q4, while pricing and geopolitics remain risks |
| JBL Jabil Inc. | FY2026 Q4 · Calendar Q3 2026 | +8.1% | -10.0% | Jabil enters FY2027 with AI-led growth and capacity risks |
| MU Micron Technology, Inc. | FY2026 Q4 · Calendar Q3 2026 | +5.4% | +0.0% | Micron: Strong AI Memory Demand, Higher Capex, and HBM4E Ahead |
| SNX TD Synnex Corp | FY2026 Q3 · Calendar Q3 2026 | +20.9% | -9.9% | TD SYNNEX: AI-led growth accelerates, but mix and cash flow matter |
| ADBE Adobe Inc. | FY2026 Q3 · Calendar Q3 2026 | +0.8% | +1.4% | Adobe raises FY26 outlook as AI strategy broadens |
| ORCL Oracle Corporation | FY2027 Q1 · Calendar Q3 2026 | +10.3% | -1.7% | Oracle raises FY27 outlook as AI demand accelerates cloud growth |
Latest beats and misses
Who reports nextBeat on EPS
Get the CDW recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2025-01-22T00:04:22.296664+00:00
- Polygon adjusted daily market bars · 2026-10-11T01:20:44.562034+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-11T01:20:44.559333+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-11. For educational purposes only; not investment advice.